Nordson posted record Q2 sales, double-digit EPS growth, and raised full-year guidance as growth broadened across industrial, medical, and semiconductor markets. The stock remains a Buy, but valuation and leverage limit upside from here.
Nordson Corporation (NDSN) earns a Buy rating for a moderate-risk, medium-term portfolio. Fiscal Q2 2026 produced record sales of $741M, up 8% year over year, 7% organic growth, adjusted EPS of $2.86, up 18%, and backlog growth of 18%. Management also raised full-year fiscal 2026 guidance to sales of $2.93B to $3.01B and adjusted EPS of $11.30 to $11.80.
The growth engine is broad rather than dependent on one product line. Advanced Technology Solutions delivered 8% organic growth and a record 27% EBITDA margin, Medical and Fluid Solutions delivered 8% organic growth, and Industrial Precision Solutions returned to normalized growth with 5% organic growth in the quarter. Semiconductor, electronics, medical, precision agriculture, packaging, and industrial coating demand all contributed to the current expansion.
The main restraint is valuation and leverage. At a latest quoted price of $295.77, NDSN trades at 32.5x trailing earnings, 24.8x forward earnings, and 1.9x PEG. Fiscal 2025 debt was $2.02B against $108.4M of cash, although quarterly net debt declined to about $1.8B and leverage reached 1.9x. The business is high quality, but the stock already prices in a meaningful share of the recovery.
Nordson, founded in 1909 and headquartered in Westlake, Ohio, designs and manufactures precision systems that dispense, apply, measure, and control adhesives, coatings, polymers, sealants, biomaterials, and other fluids. The company also provides test and inspection equipment, surface treatment systems, and medical components. NDSN trades on the NASDAQ and operates in the Industrials sector.
The company had about 8,200 employees in the corporate information provided. Its fiscal year ends in October. Products reach customers through a direct sales force, distributors, and sales representatives, while the 2025 10-K describes a worldwide network of direct sales and technical resources as a competitive advantage.
Nordson generated $2.79B of revenue in fiscal 2025, compared with $2.36B in fiscal 2021. About 33% of fiscal 2025 revenue came from the U.S. and 67% came from outside the U.S. That international footprint broadens the customer base, but it also exposes results to currency movements, trade policy, regional industrial cycles, and geopolitical disruption.
The strategy combines organic product development with acquisitions of differentiated precision-technology businesses. The March 16, 2026 acquisition of CapstanAG Systems added pulse-width-modulation technology for precision agriculture and expanded Nordson's access to mid-tier original equipment manufacturers in North America.
Industrial Precision Solutions generated Q2 fiscal 2026 sales of $350M, up 10% year over year. Organic sales increased 5%, with a 4% currency benefit and roughly 1% from the Capstan acquisition. Segment EBITDA reached $124M, equal to a 35% margin. Growth came from improving industrial coating and polymer processing systems, precision agriculture, packaging adhesive dispensing, and stable consumer and industrial demand.
Medical and Fluid Solutions generated Q2 sales of $213M, up 5% year over year. Organic sales increased 8%, led by Engineered Fluid Solutions and medical product lines, while the prior medical contract manufacturing divestiture reduced reported growth by about 4%. EBITDA was $79M, equal to a 37% margin. A regulatorily required material change created a near-term start-up and conversion headwind in selected interventional products.
Advanced Technology Solutions generated Q2 sales of $178M, up 10% year over year and 8% organically. Electronics dispense products benefited from semiconductor demand, while test and inspection orders began to improve. Segment EBITDA reached a record $48M, and the EBITDA margin expanded to 27% from 25% a year earlier.
The fiscal 2024 segment mix shows the portfolio's industrial foundation and its growth-market exposure. Industrial Precision Solutions contributed $1.48B, or 55.2%, of total revenue; Medical and Fluid Solutions contributed $695M, or 25.9%; and Advanced Technology Systems contributed $510M, or 19.0%. In fiscal 2023, the corresponding mix was 52.9%, 25.1%, and 22.0%, respectively, showing a larger Industrial Precision Solutions contribution and a smaller Advanced Technology Systems share at that point in the cycle.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
Nordson's core product proposition is precision fluid application embedded in a customer's manufacturing process. Industrial dispensing systems apply adhesives, coatings, sealants, and polymers at controlled locations and volumes. The Q2 performance of Industrial Precision Solutions, including $350M of sales and a 35% EBITDA margin, demonstrates the economic value of this application-focused product family.
The strongest current product momentum sits in electronics dispense and semiconductor-related test and inspection. Management said more than 50% of the Advanced Technology Solutions business is now tied to semiconductors. The portfolio includes automated dispensing, gas plasma treatment, bond testing, optical and acoustic microscopy, and X-ray inspection for semiconductor and printed circuit board applications.
CapstanAG adds a distinct precision-agriculture product family. Its pulse-width-modulation systems provide nozzle-by-nozzle control for row-crop, orchard, and aerial spraying. Nordson said the technology increases application efficiency and reduces waste, while the Topeka, Kansas footprint places the combined business closer to North American mid-tier OEM customers.
Medical products extend the same precision-control model into a regulated market. Nordson supplies syringes, cartridges, tips, fluid connections, tubing, balloons, balloon inflators, cannulas, nitinol devices, and biomaterial delivery systems. The 37% Q2 EBITDA margin in Medical and Fluid Solutions shows the profitability of this specialized product base despite the temporary material-change inefficiency.
Nordson's stated innovation advantage rests on differentiated precision technologies, application expertise, and a close-to-the-customer business model. The 2025 10-K describes products supported by patents, trademarks, copyrights, trade secrets, and contractual protections. These assets reinforce a product proposition built around engineering performance rather than simple equipment volume.
The application model can create switching friction because dispensing, coating, inspection, and fluid-control systems are tied to a customer's process design and production standards. Nordson's direct technical resources help it understand those processes and develop application solutions, making service and process knowledge part of the offering alongside the hardware.
The NBS Next growth framework is producing measurable operating benefits in Advanced Technology Solutions. Q2 EBITDA margin reached 27%, up from 25%, and management attributed the improvement to SG&A leverage and footprint changes made in prior years. Nordson is also developing technology for panel-level packaging and optical-fiber applications linked to AI infrastructure.
The portfolio has become more growth-oriented without abandoning steadier end markets. Management said more than 50% of the portfolio is now in semiconductor, electronics, and medical markets, with the remaining exposure in more stable GDP-plus markets. That mix supports a premium industrial profile, while the Advanced Technology Solutions cycle still introduces meaningful volatility.
Nordson operates a global manufacturing and service network with principal facilities in the U.S., China, Europe, Israel, Mexico, and other countries. The geographic structure supports the company's 67% non-U.S. revenue exposure and its stated objective of locating operations near customers.
Backlog conversion provides a useful view of operating visibility. Management said the majority of backlog turns within six months, with some orders shipping within the quarter. A minority of backlog extends into fiscal 2027. Overall backlog was up 18% year over year, and order entry was broad-based across all three segments.
The company is consolidating its existing North American precision-agriculture facilities into Capstan's Topeka footprint. In Q2, Nordson invested $10M in capital projects, reduced net debt by $93M, paid $46M in dividends, and repurchased $43M of stock. This combination shows a preference for targeted capacity investment alongside shareholder returns and debt reduction.
Supply-chain costs remain a pressure point. CFO Daniel Hopgood described components, resins, and tariffs as part of a broader inflationary environment. Nordson is using selective pricing and cost actions to protect margins. The approach preserved total Q2 EBITDA margin at 32%, although Industrial Precision Solutions delivered lower incremental conversion than its typical mid- to upper-30% range.
Nordson operates in several large markets with favorable precision and automation trends. Mordor Intelligence estimates the global industrial machinery market at $870B in 2026, rising to $1.31T by 2031. MarketsandMarkets estimates the industrial control and factory automation market at $275B in 2025 and $435B by 2030.
Electronics manufacturing is the most important near-term growth market for NDSN. SEMI forecast global semiconductor manufacturing equipment sales of $125.5B in 2025, up 7.4% year over year, with AI and high-bandwidth-memory complexity supporting demand. Nordson's Q2 ATS sales rose 10%, and management described the semiconductor cycle as being in its early stages.
Automation and smart-manufacturing investment also support Nordson's product categories. MarketsandMarkets estimates the industrial automation market at about $220B in 2025 and about $480B in 2035. Its smart-manufacturing estimate rises from $333B in 2025 to $996B in 2030. These figures align with Nordson's exposure to automated dispense, testing, inspection, measurement, and control.
The market is not uniformly strong. Management described general automotive electronics growth as muted, while automotive, polymer processing, industrial coatings, consumer nondurables, and medical applications showed different recovery patterns. That dispersion favors Nordson's multi-segment structure, but it also means the company's growth rate remains tied to capital spending and production volumes in specific end markets.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
Nordson serves manufacturers in electronics, semiconductors, medical devices, packaging, consumer nondurables, automotive, plastics, industrial coatings, and precision agriculture. The company sells through direct channels, distributors, and sales representatives, giving it access to both major industrial customers and specialized regional OEMs.
The customer relationship is technical and process-specific. Nordson's 10-K emphasizes understanding customer processes and developing application solutions, while management highlights a close-to-the-customer model. This setup supports repeat demand for replacement parts, service, consumables, and single-use products after the initial equipment sale.
Management said about 60% of the business consists of consumables and single-use products with near-term turnover. That mix provides a recurring demand element even when equipment purchases move through a cycle. In Advanced Technology Solutions, management also cited customer diversification away from reliance on one or two large customers, reducing concentration risk within that segment.
Medical customers add a regulated and technically demanding channel. Q2 medical product growth returned to 8% organically, and management described a 6% to 8% normalized growth target for the medical business. The quarter's material-change issue was tied to a regulatory requirement, highlighting both the compliance burden and the high technical standards of this customer base.
Graco is the closest named competitor in industrial dispensing, fluid handling, sealant, and adhesive applications. IDEX overlaps with Nordson in precision fluidics, pumps, valves, and medical-adjacent components. In electronics manufacturing, the relevant competitive group includes MKS Instruments, Advanced Energy, Keysight, Entegris, and ASMPT-type equipment providers.
Medical component comparisons include Integer and Merit Medical, while Nordson's broader industrial peer universe includes AMETEK, Lincoln Electric, Vontier, Trimble, Crane, Donaldson, Pentair, ITT, Watts, and Woodward. The comparison set is broad because NDSN combines industrial dispensing, medical components, fluid management, electronics manufacturing, and inspection.
Nordson competes through application-specific equipment, technical support, direct customer access, and a global service network. The Q2 performance supports that positioning: all three segments delivered organic growth, Advanced Technology Solutions expanded its margin to 27%, and backlog rose 18% across the company.
The primary competitive risk is that Nordson participates in markets where alternative bonding, sealing, coating, processing, testing, and inspection methods exist. The 2025 10-K also identifies competition from established manufacturers and service providers. Nordson's application expertise and intellectual-property portfolio support differentiation, but the premium valuation leaves less room for execution mistakes.
Nordson's 67% non-U.S. revenue exposure makes currency and regional conditions important. Currency translation added 3% to Q2 sales growth. Management expects foreign exchange to be neutral year over year in the second half of fiscal 2026, removing a recent tailwind from the reported growth comparison.
Trade policy is a direct operating variable. Nordson sources materials globally and identifies tariffs, especially on imports from China, as a cost-of-goods risk. CFO Daniel Hopgood said tariffs were not material by themselves in Q2, but they formed part of the broader inflationary pressure affecting components, resins, and other inputs.
Geopolitical exposure also matters because the 2025 10-K identifies conflicts in Europe and the Middle East as potential sources of volatility and disruption. Facility interruptions, transport constraints, export controls, and changes in protectionist policy can affect production, delivery, and foreign sales.
The macro picture is mixed but currently constructive for NDSN. Semiconductor demand, AI infrastructure, industrial automation, medical technology, and supply-chain localization support investment. Automotive electronics remains muted, while improving industrial coatings and polymer processing helped IPS. NDSN's beta of 1.0, rounded from 0.964, points to market sensitivity close to the broader equity market rather than an extreme cyclical profile.
Net debt fell to about $1.8B and leverage improved to 1.9x, but Nordson still carried $2.02B of debt against just $108.4M of cash at fiscal 2025 year-end.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Revenue reached a record $741M in Q2, with adjusted EPS up 18% to $2.86 and Advanced Technology Solutions posting a 27% EBITDA margin.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Management lifted fiscal 2026 guidance to $2.93B-$3.01B of sales and $11.30-$11.80 of adjusted EPS after 18% backlog growth.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →At $295.77, Nordson trades at 32.5x trailing earnings, 24.8x forward earnings, and 1.9x PEG, leaving less room for multiple expansion.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →The report’s fair value sits at $320, above the current quote but below the $350 and $380 downside scenarios that frame the stock’s valuation range.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Nordson is executing from a position of strength. Fiscal Q2 2026 delivered $741M of record sales, $235M of EBITDA, $2.86 of adjusted EPS, and $175M of free cash flow. All three segments contributed to organic growth, and Advanced Technology Solutions produced the clearest combination of semiconductor exposure, backlog momentum, and margin expansion.
The balance sheet is moving in the right direction through debt reduction, pension-risk reduction, and strong cash conversion. The investment case also has credible structural support from application-specific engineering, a direct technical-sales network, recurring consumables exposure, and a growing mix of medical, electronics, and semiconductor applications.
The stock deserves a Buy rating, not a chase. At $295.77, the combination of a 32.5x trailing P/E, 24.8x forward P/E, and $2.02B fiscal 2025 debt leaves valuation discipline essential. Investors who enter with a medium-term horizon can participate in the raised earnings trajectory while recognizing that tariffs, currency, medical product conversions, and semiconductor-cycle reversals remain the principal risks.
Get AI-powered research reports, daily market intelligence, and a personal analyst in your pocket.
Get Full Access →Not ready to subscribe? ·
Cancel anytime
Nordson Corporation (NDSN) rises after delivering a fiscal third-quarter earnings beat, raising full-year guidance and reporting a 35% backlog increase. The stock moved above its 52-week high on heavier-than-average volume, signaling strong investor confidence in the company’s growth and margin outlook.
Nordson Corporation (NDSN) gains after topping both EPS and revenue estimates, with the latest quarter showing stronger sales momentum and record-high earnings in the recent sequence. The deep dive also points to improving segment performance, solid backlog trends, and continued analyst support.
Nordson Corporation (NDSN) climbs 10.1% after reporting earnings beats, lifting investor sentiment as the industrial equipment maker tops expectations.